Stryker Corp (FRA:SYK)
€ 306.9 0 (0%) Market Cap: 117.29 Bil Enterprise Value: 127.02 Bil PE Ratio: 37.59 PB Ratio: 6.54 GF Score: 94/100

Stryker Corp at Morgan Stanley Healthcare Conference Transcript

Sep 10, 2019 / 12:35PM GMT
Release Date Price: €191.38 (-3.48%)
David Ryan Lewis
Morgan Stanley, Research Division - MD

Well, let's get going here. Big room here in the morning. My name is David Lewis, medical device analyst for Morgan Stanley. It's my pleasure to have with us here this morning Stryker and their Chief Executive Officer, Kevin Lobo.

Before we begin, please go to my Morgan Stanley's research disclosure website and check out my research disclosures to see some fun and fancy facts about me.

Questions & Answers

David Ryan Lewis
Morgan Stanley, Research Division - MD

So Kevin, I wanted to start, similar place we started this morning for our breakfast, but you recently did an acquisition of Mobius and it brings up 2 important dynamics that I want to talk about. The first is there's a tension in this conference for the executives, CEOs pulling me aside and saying, hey, what do we think about these relative rates of med tech valuations. And the companies have taken 2 tacks. One is some have gone aggressive on M&A. You've done about $14 billion, $15 billion of M&A during your tenure.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot